• Dr Radoslaw Janiak

FutureMeds opens first clinical trial site in Wroclaw, Poland

FutureMeds, a new independent Site Management Organisation, has opened its first site in Wroclaw, Poland.  The site is the first of a number of planned new site openings across Europe as FutureMeds looks to establish itself as a key provider of services to CROs and pharma companies.

With an initial focus on primary care trials, FutureMeds aim to recruit patients and run clinical trials in therapy areas including cardiovascular, rheumatology, respiratory, NASH, diabetes, CNS, dermatology, women’s health, metabolic disease and vaccines.